BackBrooklyn ImmunoTherapeutics Overview

Brooklyn ImmunoTherapeutics Current Assets

Brooklyn ImmunoTherapeutics's current assets is $1.4M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$1.39M

Peer average

Loading

Brooklyn ImmunoTherapeutics Current Assets History

Loading

Brooklyn ImmunoTherapeutics vs. peers: Current Assets Comparison

Loading

Brooklyn ImmunoTherapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Brooklyn ImmunoTherapeutics (BTX) FAQ

As of the most recent data (December 2025), BTX shows a current assets of $1.4M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BTX's current assets is now $1.4M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Brooklyn ImmunoTherapeutics is outperforming or lagging.

Tracking BTX's current assets over time shows whether Brooklyn ImmunoTherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Brooklyn ImmunoTherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $1.4M) with ownership activity and broader fundamentals.

Brooklyn ImmunoTherapeutics's current assets is $1.4M; compare it with other Telecommunications names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.